Subsection 2: Healthcare waste produced by patients undergoing self-treatment and users of self-tests

For the purposes of this sub-section, the following definitions apply: 1° Perforating waste from healthcare activities: any waste from healthcare activities with infectious risks meeting the requirements of a of 2° of Article R. 1335-1; 2° Medicinal product: any medicinal product within the meaning of Article L. 5111-1, whether or not combined with perforating medical devices within the meaning of 3° of this article, or with electrical or electronic equipment…

I.-This sub-section implements the principle of extended producer responsibility, provided for by the provisions of article L. 4211-2-1 and those of I of article L. 541-10 of the Environment Code, to which the producers of perforating medical devices referred to in 3° of article R. 1335-8-1 of the present code are subject, subject to II of the present article, and defines the procedures for managing the waste from these devices….

Producers or the eco-organisation to which they belong pursuant to article L. 541-10 of the Environment Code provide pharmacies and pharmacies for internal use, free of charge, with packaging designed to collect the waste mentioned in 3° of article R. 1335-8-1 of this Code. The producers or the eco-organisation to which they belong take back free of charge or have taken back free of charge the waste mentioned in the…

Pharmacy pharmacies and pharmacies for internal use providing onward dispensing of medicinal products provide each patient undergoing self-treatment and each user of self-tests using perforating medical devices with packaging adapted to the type of waste resulting from the use of the device, free of charge.

I.-Pharmacies are required to collect, free of charge, the waste mentioned in 3° of article R. 1335-8-1. Pharmacies for internal use and medical biology laboratories wishing to collect this waste free of charge must make a declaration to the regional prefect, by any means giving a date certain for receipt of this declaration. The list of these pharmacies for internal use and medical biology laboratories is drawn up, in each…

I.-The waste mentioned in 4° of article R. 1335-8-1 is managed under the following conditions: 1° By way of derogation from the first paragraph of article R. 1335-6, this waste is collected separately in suitable packaging in order to allow its recovery and prevent the risks associated with its collection; 2° By way of derogation from article R. 1335-7, the duration of storage of this waste is adapted to its…

The financing of collection systems and operations for the prevention, collection, transport and treatment of waste arising from the use of the products mentioned in 2°, 3° and 4° of article R. 1335-8-1 is subject to the provisions of article R. 541-119 of the Environment Code and the following conditions: 1° The financial contribution provided for in article L. 541-10-2 of the Environment Code is divided according to a ratio…